Patents by Inventor Shuhei KANESATO

Shuhei KANESATO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100227
    Abstract: Provided is a novel device or a novel implantation device. The implantation device is one of the following: (1) an implantation device comprising a material (A) having a density of 12 mg/cm3 or more and a dissolution rate of 80% or less as determined after immersion of the material (A) in physiological saline at 37° C. for 24 hours; and (2) an implantation device comprising a material (A) having a dissolution rate of 80% or less as determined after immersion of the material (A) in physiological saline at 37° C. for 24 hours and a ratio of X/Y of 0.24 or more wherein X is a density (mg/cm3) of the material (A) and Y is a degree of swelling of the material (A) expressed in terms of fold increase as determined after immersion of the material (A) in physiological saline at 37° C. for 60 minutes.
    Type: Application
    Filed: February 8, 2022
    Publication date: March 28, 2024
    Applicants: Shin-Etsu Chemical Co., Ltd., JAPAN VAM & POVAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Shuhei KANESATO, Yoshihiro KIMURA, Akinobu OHARUDA, Keita ISHIBA, Masafumi GOTO
  • Publication number: 20240091404
    Abstract: Provided is a novel device (implantation device) containing a gelatin. The implantation device is made of a bioabsorbable non-woven fabric containing a gelatin.
    Type: Application
    Filed: February 8, 2022
    Publication date: March 21, 2024
    Applicants: Shin-Etsu Chemical Co., Ltd., JAPAN VAM & POVAL CO., LTD., TOHOKU UNIVERSITY, KYOTO MEDICAL PLANNING Co., Ltd
    Inventors: Shuhei KANESATO, Yoshihiro KIMURA, Akinobu OHARUDA, Masafumi GOTO
  • Publication number: 20230070463
    Abstract: The present invention provides a novel angiogenesis device. The angiogenesis device comprises an angiogenic component and a polymer, and is used to induce angiogenesis at a site for implantation of a cell- or tissue-containing device. The polymer may comprise, for example, at least one or more polyvinyl alcohol resins (A) selected from a modified polyvinyl alcohol resin having an active carbonyl group (A1), a polyvinyl alcohol resin having a triad syndiotacticity of 32 to 40% (A2), and a polyvinyl alcohol resin having a degree of saponification of 97 mol % or more (A3).
    Type: Application
    Filed: February 3, 2021
    Publication date: March 9, 2023
    Applicants: Shin-Etsu Chemical Co., Ltd., JAPAN VAM & POVAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Shuhei KANESATO, Yoshihiro KIMURA, Akinobu OHARUDA, Masafumi GOTO
  • Publication number: 20230076461
    Abstract: The present invention provides a novel angiogenesis device. The angiogenesis device comprises an angiogenic component and a polymer. The polymer may comprise, for example, at least one or more polyvinyl alcohol resins (A) selected from a modified polyvinyl alcohol resin having an active carbonyl group (A1), a polyvinyl alcohol resin having a triad syndiotacticity of 32 to 40% (A2), and a polyvinyl alcohol resin having a degree of saponification of 97 mol % or more (A3).
    Type: Application
    Filed: February 3, 2021
    Publication date: March 9, 2023
    Applicants: Shin-Etsu Chemical Co., Ltd., JAPAN VAM & POVAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Shuhei KANESATO, Yoshihiro KIMURA, Akinobu OHARUDA, Masafumi GOTO